连续流左心室辅助装置支持患者的主动脉根部血栓
该研究回顾性分析了哥伦比亚大学医学中心2004年4月至2016年6月植入HeartMate II或HeartWare HVAD连续流左心室辅助装置(CF-LVAD)的436例患者,系统复习超声心动图以识别主动脉根部血栓(ART)。21例(4.8%)确诊ART,诊断中位时间为植入后22天(IQR 3至56天),非冠状动脉瓣受累最常见(n=15,71.4%),合并右心衰14例(66.7%);ART诊断后1年和2年生存率分别为73.8%和44.3%,卒中与临床显著心肌梗死均为28.6%(0.337 EPPY)。
要点
- CF-LVAD植入后ART发生率为4.8%,诊断中位时间仅22天,需早期警惕。
- 非冠状动脉瓣受累最常见(71.4%),常合并右心衰(66.7%)。
- ART后卒中与临床显著MI各占28.6%,2年生存率降至44.3%。
核心结论
- ART在CF-LVAD植入后并不少见,并与显著的并发症发生率和死亡率相关。
- 鉴于ART发生早且卒中、MI发生率高,应实施监测和治疗策略以应对这一潜在灾难性并发症。
研究设计与样本
- 回顾性队列研究,纳入2004年4月至2016年6月在哥伦比亚大学医学中心植入HeartMate II或HeartWare HVAD CF-LVAD的全部患者,共436例。
- 系统复习超声心动图以识别发生ART的患者,研究终点包括ART后CF-LVAD支持生存、卒中、泵血栓和临床显著心肌梗死。
主要发现
- 436例CF-LVAD患者中21例(4.8%)确诊ART,诊断中位时间为植入后22天(IQR 3至56天)。
- 非冠状动脉瓣受累最常见(n=15,71.4%),合并右心衰14例(66.7%)。
- ART诊断后1年和2年 actuarial 生存率分别为73.8%和44.3%。
- ART患者并发症发生率高,卒中28.6%(0.337 EPPY),临床显著MI 28.6%(0.337 EPPY)。
临床怎么用
- 对CF-LVAD植入患者应重视主动脉根部血栓的早期监测,尤其关注非冠状动脉瓣及合并右心衰者。
- 对确诊ART者需警惕卒中和心肌梗死,并据此制定监测与治疗策略。
局限性
- 为单中心回顾性研究,ART依赖超声心动图系统复习识别,可能存在检出偏倚。
- 样本中ART病例仅21例,事件数有限,结果需更大队列验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aortic root thrombosis (ART) is a recently recognized complication of continuous-flow left ventricular assist device (CF-LVAD) therapy. However, little is known about the prevalence or clinical significance of this complication. The aim of our study was to systematically evaluate the incidence and significance of ART on CF-LVAD support. METHODS: We retrospectively reviewed all patients who underwent HeartMate II or HeartWare HVAD CF-LVAD implantation from April 2004 through June 2016 at the Columbia University Medical Center. Echocardiography studies were systematically reviewed to identify patients who developed ART. Study outcomes included post-ART survival on CF-LVAD support, stroke, pump thrombosis, and clinically significant myocardial infarction (MI). RESULTS: The study cohort consisted of 436 CF-LVAD patients with 21 patients (4.8%) diagnosed with confirmed ART at a median time of 22 days (interquartile range [IQR] 3 to 56 days) after CF-LVAD implantation. Involvement of the non-coronary cusp was the most common location of the ART (n = 15, 71.4%) and concomitant RV failure occurred in 14 patients (66.7%). Actuarial survival at 1 and 2 years after diagnosis of ART was 73.8% and 44.3%, respectively. ART was associated with a high rate of complications, including stroke (28.6%, 0.337 episode per patient-year [EPPY]) and clinically significant MI (28.6%, 0.337 EPPY). CONCLUSIONS: ART is not uncommon after CF-LVAD implantation and is associated with significant morbidity and mortality in CF-LVAD patients. Given the early occurrence and high incidence of stroke and MI in patients who develop ART, surveillance and treatment strategies should be implemented to address this potentially devastating complication.
引用
- Fried J, Garan AR, Shames S, et al. Aortic root thrombosis in patients supported with continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2018. PMID: 30241886. doi:10.1016/j.healun.2018.07.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。